Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Kardigan has raised $254.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Kardigan's investors include ARCH Venture Partners, Perceptive Advisors, Fidelity, T. Rowe Price, Sequoia Heritage.
Kardigan is headquartered in South San Francisco, United States.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Kardigan is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kardigan — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/kardigan. Accessed October 31, 2026.
VCBacked. (2025). Kardigan — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/kardigan
{{cite web |title=Kardigan — Funding & Investors |url=https://www.vcbacked.co/company/kardigan |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated